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Measuring the depth of invasion in vulvar squamous cell carcinoma: interobserver agree-
ment and pitfalls
Aims: The depth of invasion is an important prog-
nostic factor for patients with vulvar squamous cell
carcinoma (SCC). The threshold of 1 mm distin-
guishes between FIGO stages IA and ≥IB disease and
guides the need for groin surgery. Therefore, high
interobserver agreement is crucial. The conventional
and the alternative method are described to measure
the depth of invasion. The aims of this study were to
assess interobserver agreement for classifying the
depth of invasion using both methods and to identify
pitfalls.
Methods and results: Fifty slides of vulvar SCC with a
depth of invasion approximately 1 mm were selected,
digitally scanned and independently assessed by 10
pathologists working in a referral or oncology centre
and four pathologists in training. The depth of inva-
sion was measured using both the conventional and
alternative method in each slide and categorised into
≤1 and >1 mm. The percentage of agreement and
Light’s kappa for multi-rater agreement were calcu-
lated, and 95% confidence intervals were calculated
by bootstrapping (1000 runs). The agreement using
the conventional method was moderate (j = 0.57,
95% confidence interval = 0.45–0.68). The percent-
age of agreement among the participating patholo-
gists using the conventional method was 85.0%
versus 89.4% using the alternative method. Six pit-
falls were identified: disagreement concerning which
invasive nest is deepest, recognition of invasive
growth and where it starts, curved surface,
Address for correspondence: A. W. Pouwer, Department of Obstetrics and Gynaecology (791), Radboud University Medical Center, PO
Box 9101, 6500 HB Nijmegen, the Netherlands. e-mail: anne-floor.w.pouwer@radboudumc.nl
© 2019 The Authors. Histopathology Published by John Wiley & Sons Ltd..
This is an open access article under the terms of the Creative Commons Attribution License, which permits use,
distribution and reproduction in any medium, provided the original work is properly cited.
Histopathology 2019, 75, 413–420. DOI: 10.1111/his.13883
carcinoma situated on the edge of the tissue block,
ulceration and different measurement methods.
Conclusions: Pathologists reached only moderate
agreement in determining the depth of invasion in
vulvar SCC, without a notable difference between the
two measurement methods.
Keywords: depth of invasion, interobserver agreement, vulvar neoplasm, vulvar squamous cell carcinoma
Introduction
It is generally accepted that tumour thickness and/or
depth of invasion (DOI) is a reliable parameter for
predicting the likelihood of regional lymph node
involvement and survival in many malignancies,
such as cervical, head and neck and colorectal
cancers.1–3 The DOI is also an important prognostic
factor in patients with vulvar squamous cell carci-
noma (SCC) and determines the need for groin sur-
gery. Early-stage vulvar SCC is treated by radical
local excision of the tumour, with or without ingui-
nofemoral lymph node staging, depending on the
DOI.4 In patients with a microinvasive carcinoma
(DOI ≤1 mm, FIGO stage IA), the risk of inguinofe-
moral lymph node metastases is negligible and lymph
node staging can be safely omitted.5,6 In patients
with macroinvasive disease (DOI >1 mm, FIGO stage
≥IB), a sentinel node procedure and/or an inguinofe-
moral lymphadenectomy is indicated. Inguinofemoral
lymphadenectomy is also associated with significant
morbidity. This morbidity encompasses short-term
morbidity, including wound infection, formation of
lymphoceles and/or wound breakdown in up to 85%
of the patients, and long-term morbidity, including
lymphoedema, cellulitis and erysipelas in up to 64%
of the patients.7–9 Because of the far-reaching conse-
quences of inguinofemoral lymphadenectomy, classifi-
cation of the DOI with a threshold of 1 mm is crucial
and high interobserver agreement is important.
Wilkinson et al.10 have described a number of
methods for measuring the DOI in vulvar SCC. The
International Federation of Gynecology and Obstetrics
(FIGO) recommend to: ‘measure from the epithelial–
stromal junction of the most superficial adjacent der-
mal papillae to the deepest point of invasion’, as
shown in Figure 1, method A.11 In many carcinomas
such as cervical cancer, the depth of invasion is mea-
sured from the nearest dysplastic crypt or surface
epithelium,1 because logically tumour cells will origi-
nate from the nearest rete ridges instead of the most
superficial dysplastic epithelium. In vulvar cancer,
this measurement method (measurement from the
most adjacent dysplastic abnormal rete ridge to the
deepest point of invasion) is analogous to the method
used in cervical cancer (see Figure 1, method B).
This alternative measurement method has been
studied by Van den Einden et al.12; they performed a
retrospective study comparing the DOI measured by
both the conventional and alternative method in a ser-
ies of vulva carcinoma, and concluded that the alterna-
tive method may provide a better reflection of the
prognosis. With a cut-off of 1 mm for both methods,
the alternative method resulted in downstaging of the
FIGO stage to IA (DOI ≤1 mm) in 9% of the patients
(14 of 148). In 13 patients (19%) with FIGO stage IB
disease the carcinoma was downstaged to stage IA, in
which no groin surgery is indicated. In none of patients
was there evidence of lymph node metastasis. How-
ever, in one downstaged patient from FIGO stage IIIA
isolated tumour cells were present in the lymph node
removed by the sentinel node technique.
The question was raised of whether there is a dif-
ference in the interobserver agreement when patholo-
gists use the method recommended by FIGO or an
alternative method as described above. We aimed to
assess the interobserver agreement between patholo-
gists using two different measurement methods and
to identify pitfalls in the assessment of the DOI.
Methods
Slides from biopsies and/or surgical resection speci-
mens of patients treated for vulvar squamous cell car-
cinoma at the Radboud University Medical Center
between 2000 and 2017 were retrieved. An expert
gynaecological pathologist (J.B.) reviewed and
selected slides for inclusion; both diagnostically chal-
lenging and straightforward slides were selected, rep-
resenting daily practice. In all slides there was a DOI
of approximately 1 mm; approximately half the slides
showed a DOI ≤1.0 mm and half >1.0 mm at the ini-
tial histopathological examination measured by the
conventional method. The area of invasion was cir-
cled on the slide and all slides were anonymised.
All slides were assessed independently by all partici-
pants working in either a gynaecological oncology
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centre or a referring hospital. The expert pathologist
(J.B.) who selected the slides for inclusion did not par-
ticipate in the study. For each individual slide, partici-
pants measured the DOI using both the conventional
and the alternative methods using a digital ruler. The
digital ruler measures the distance between two loca-
tions and a straight line was displayed. Each mea-
surement was reported in mm, with an accuracy of 1
decimal point in an online questionnaire using Castor
EDC.13 After assessing the slides, the participants
recorded how certain they were about each measure-
ment and noted any difficulties and/or comments.
Furthermore, the participants were asked what
method they used in daily practice and how many
years of experience they had.
We based our sample size on a previous study
which evaluated the interobserver agreement when
assessing the DOI of vulvar SCC.14 We estimated that
the kappa for interobserver agreement for the DOI ≤1
versus >1 mm using the conventional measuring
method would be approximately 0.70 [standard devi-
ation (SD) = 0.10]. With 10 participating patholo-
gists, a power of 80%, an alpha of 5% and a two-
sided 95% confidence interval (CI) of maximal 0.10,
50 slides were required for pathological assessment.15
In addition, we included four pathology residents to
assess all 50 slides in order to identify differences in
the interobserver agreement between residents and
pathologists.
The slides were digitally scanned (Pannoramic
P250 Flash II; 3DHistech) and distributed to the par-
ticipants using tEPIS (Trait Enhanced Pathology
Image Sharing-system), a digital pathology platform.
The participants were not informed about the original
diagnosis, did not receive any clinical information
and were not aware of the measurements made by
other participants. The participants received Figure 1
as instruction on how to perform both measurement
methods. The conventional method was defined as:
‘measurement(s) from the epithelial–stromal junction
of the most superficial adjacent dermal papillae to the
deepest point of invasion’. The alternative method
was defined as: ‘measurement from the most adjacent
dysplastic abnormal rete ridge to the deepest point of
invasion’.
The annotations made on the slides by each partic-
ipant were visible to the researcher and were
reviewed by the expert gynaecological pathologist
(J.B.); this gave the pathologist insight into where
exactly the measurement had been made, and
allowed review of the discordant slides and analysis
of the reasons for discrepancies to identify pitfalls.
S T A T I S T I C A L A N A L Y S I S
For purposes of analysis, the DOI measurements were
dichotomised into two categories, DOI ≤1.0 and
>1.0 mm, as this categorisation is clinically relevant.
Keratin layer
Epidermis
A B
Tumor
Figure 1. Measurement
methods for the depth of
invasion in vulvar squamous
cell carcinoma. Method A:
conventional method;
measurement(s) from the
epithelial–stromal junction of
the most superficial adjacent
dermal papillae to the deepest
point of invasion. Method B:
alternative method;
measurement from the most
adjacent dysplastic abnormal
rete ridge to the deepest point
of invasion.
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The percentage of interobserver agreement was calcu-
lated separately for the conventional and the alterna-
tive methods for diagnostically challenging and
straightforward slides, and for pathologists working
in a gynaecological oncology centre or referring hos-
pital. Light’s kappa for multi-rater agreement was cal-
culated for the conventional method and 95% CIs
were calculated by bootstrapping (1000 runs). Kappa
values were interpreted as slight (<0.21), fair (0.21–
0.40), moderate (0.41–0.60), substantial (0.61–0.80)
or almost perfect (0.81–0.99) interobserver agree-
ment.16
A slide was arbitrarily defined as discordant if there
was agreement on the DOI, classified as microinvasive
(DOI ≤1 mm, FIGO stage IA) or macroinvasive (DOI
>1 mm, FIGO stage ≥IB) among fewer than seven of
10 pathologists (≤60%), using either the conventional
or the alternative method. The statistical software R
was used for statistical analysis (version 3.3.2) with
the ‘irr’ package.
E T H I C S S T A T E M E N T
Anonymised residual tissue was used, which was
retrieved during regular treatment. According to
Dutch law, no specific patient approval is necessary
for the use of this material. This study was approved
by the local ethical committee (number 2016-2728)
and performed according to the Code for Proper Sec-
ondary Use of Human Tissue (Dutch Federation of
Biomedical Scientific Societies (htpp://federa.org).
Results
Of the 50 slides selected, 24 (48%) were diagnosed as
microinvasive (DOI ≤1 mm, FIGO stage IA) and 26
(52%) macroinvasive (DOI >1 mm, FIGO stage ≥IB)
at initial histopathological examination. Ten patholo-
gists assessed all 50 slides; there was a median of
10 years’ experience as a pathologist (range = 0.5–
35 years). Five pathologists worked in a gynaecologi-
cal oncology centre and five in a referring hospital,
all within Europe; eight in the Netherlands, one in
Belgium and one in Spain. Additionally, four resi-
dents, all working in an oncology centre in the
Netherlands, assessed all study slides. According to
the participating pathologists, microinvasive growth
(DOI ≤1 mm, FIGO stage IA) was present in 32–72%
and macroinvasive growth (DOI >1 mm, FIGO stage
≥IB) in 22–66% of the study slides using the conven-
tional method; see Table 1. The alternative method
resulted in downgrading from macroinvasive growth
(DOI >1 mm or FIGO stage ≥IB) into microinvasive
growth (DOI ≤1 mm, FIGO stage IA) in 52–80% of
the slides assessed as macroinvasive (DOI >1 mm or
FIGO stage ≥IB) growth using the conventional
method; see Table 1.
The agreement among pathologists in the assess-
ment of the DOI was moderate (j = 0.57, 95%
CI = 0.45–0.68) using the conventional method. The
percentage of agreement among the participating
pathologists using the conventional method was
85.0% versus 89.4% using the alternative method.
Table 1. Measurements of pathologists using the conventional method in relation to the original diagnosis and the number
of slides downgraded from macroinvasive (DOI >1 mm, FIGO stage ≥IB) to microinvasive (DOI ≤1 mm, FIGO stage IA)
using the alternative method to measure the depth of invasion
Pathologist Microinvasive n (%) Macroinvasive n (%) Not assessed n (%) Downgraded n (%)
Original diagnosis 24 (48) 26 (52)
1 19 (38) 30 (60) 1 (2) 21/30 (70)
2 21 (42) 29 (58) 0 16/29 (55)
3 19 (38) 31(62) 0 20/31 (65)
4 26 (51) 23 (47) 1 (2) 12/23 (52)
5 20 (40) 30 (60) 0 24/30 (80)
6 17 (34) 33 (66) 0 19/33 (59)
7 36 (72) 11 (22) 3 (6) 6/11 (55)
8 20 (40) 30 (60) 0 23/30 (77)
9 16 (32) 32 (64) 2 (4) 22/32 (69)
10 25 (50) 24 (48) 1 (2) 13/24 (54)
© 2019 The Authors. Histopathology Published by John Wiley & Sons Ltd., Histopathology, 75, 413–420.
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As shown in Table 2, in diagnostically challenging
slides the agreement was higher using the alternative
compared to the conventional method.
Pathologists working in an oncology centre
reached higher agreement than those from the refer-
ring centres for both the conventional method
(88.0% versus 83.2%, respectively) and the alterna-
tive method (91.6% versus 88.8%, respectively); see
Table 2. Using the conventional method, full agree-
ment by the pathologists was obtained in 34% (17 of
50) of the slides and five slides (five of 50, 10%) were
considered as discordant; in one slide agreement was
40%, in two 50% and in two 60%. For measure-
ments made by the alternative method, full agree-
ment by the pathologists was obtained in 54% (27 of
50) of the slides and four slides were considered as
discordant; agreement was 50% in one and 60% in
the others. One slide was included in both groups.
As shown in Table 2, agreement between residents
was 93.5% using the conventional method and
89.5% using the alternative method. There was full
agreement between all four residents in 84% (42 of
50) and 72% (36 of 50) of the slides, respectively.
There were more discordant slides using the alterna-
tive method (10%) compared to the conventional
method (6%).
Of the 10 participating pathologists, seven (70%)
used the conventional method and two (20%) the
alternative method to measure the DOI in daily prac-
tice. One (10%) pathologist used a combination of the
two methods, using the alternative method in tumours
with early stromal invasions or microinvasion.
Three of the four (75%) residents used the conven-
tional method in daily practice. One (25%) used a
combination of the conventional and alternative
methods (the alternative method in certain cases with
microinvasion).
All pathologists scored ease of use on a scale from
1 to 5 (1 = very difficult, 5 = very easy). The ease of
use for the conventional method was scored as a
median 4 of 5 points (range = 1–5), and the alterna-
tive method as a median 4 of 5 points (range = 1–4).
Half the pathologists (five of 10) scored both methods
equally, three pathologists gave the conventional
method a higher score and two scored the alternative
method more highly.
All pathologists scored how sure they were about
their measurement on a scale of 1 to 5 (1 = not sure
at all, 5 = very sure). Eight pathologists were equally
sure about their measurement using both methods;
one pathologist was more sure about the measure-
ments using the conventional method and one using
the alternative method. The overall score was median
3 for the conventional method versus median 3 for
the alternative method.
Discordant slides were reviewed by the expert
gynaecological pathologist (J.B.) to analyse the rea-
sons for discrepancies. This resulted in the identifica-
tion of six pitfalls in the assessment of the DOI: (1)
disagreement on which invasive nest is deepest (Fig-
ure 2A–C), (2) the recognition of whether or not
there is, in fact, invasive growth and where it starts
(Figure 2B–F), (3) a curved surface (Figure 2G), (4) a
carcinoma situated on the edge of the tissue block
(Figure 2H), (5) ulceration (Figure 2I) and (6) differ-
ent methods are used to measure the DOI (Figure 2J).
Subsequently, the recommended measurements by
the expert gynaecological pathologist are displayed in
red in Figure 2.
Table 2. Agreement among pathologists (n = 10) and
pathologists in training (n = 4) in assessing the depth of
invasion
Subgroups
Conventional
method (%)
Alternative
method
Pathologists
Overall agreement 85.0 89.4
Slides
Straightforward
(n = 30)
86.3 91.3
Diagnostically
challenging (n = 20)
83.0 86.5
Type of centre
Oncology (n = 5) 88.0 91.6
Referring (n = 5) 83.2 88.8
Slides with full agreement 34.0 54.0
Discordant slides
(agreement ≥60%)
10.0 8.0
Residents
Overall 93.5 89.5
Slides
Straightforward
(n = 30)
95.8 90.8
Diagnostically
challenging (n = 20)
90.0 87.5
Slides with full agreement 84.0 72.0
Discordant slides
(agreement ≤60%)
6.0 10.0
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Discussion
A threshold of 1 mm in the DOI distinguishes
between micro- and macroinvasive growth (FIGO
stages IA and ≥IB) and guides the need for groin sur-
gery. Reproducibility of this measurement is impor-
tant and clinically relevant. However, among
pathologists there is only moderate agreement
(j = 0.57, 95% CI = 0.45–0.68) in the assessment of
the DOI using the conventional method recom-
mended by the FIGO.
The results of our study, showing moderate
(j = 0.51) interobserver agreement between 11
pathologists for classifying the DOI, are in line with
another study.14 Our study encouraged the partici-
pants to use the conventional method to measure the
DOI, but only one of 11 participants was able to use
this method in all 45 cases. This underlines the diffi-
culty of measuring the DOI in vulvar SCC and the
variation in methods of measurement used by pathol-
ogists. Our study confirms the result that measuring
invasion depth is indeed difficult in vulvar SCC. Addi-
tionally, we offer a unique insight into the difficulties
of measuring the depth of invasion by the use of digi-
tal pathology. In-depth analyses of all discrepant
slides identified six pitfalls. Based on the depicted pit-
falls, we formulated recommendations for assessing
the DOI in vulvar SCC, as displayed in Table 3.
Besides these recommendations, further improvement
can be achieved by education, for which the discor-
dant slides and the formulated pitfalls and recommen-
dations of our study are an excellent base.
We showed that pathologists reach similar agree-
ment for the classification of the DOI into a micro- or
macroinvasive carcinoma (FIGO stages IA and ≥IB)
using the conventional and alternative methods. In
contrast, pathologists in training reached higher
agreement using the conventional method. This might
be explained by recent training concerning the con-
ventional method, and therefore more homogeneity.
The strengths of our study are the international
participation in the study, the participation of pathol-
ogists working in both referring and oncology centres
and the inclusion of slides representing daily clinical
practice, i.e. both straightforward and diagnostically
challenging slides. In addition, for several reasons, a
unique strength is the use of digital pathology. First,
digital pathology uses a digital ruler and makes it
A
C
E
G
I J
H
F
B
D
500 µm
500 µm
500 µm
500 µm
500 µm
500 µm
1 mm
500 µm
500 µm
1 mm
Figure 2. Depth of invasion measured by different pathologists in
discordant slides. The yellow and green lines are a measurement of
at least one pathologist; macroinvasive [depth of invasion (DOI)
>1 mm, FIGO stage ≥IB] measurements are displayed in yellow,
microinvasive (DOI ≤1 mm, FIGO stage IA) measurements are dis-
played in green. The recommended measurement is displayed in
red. A,B,C,G,H, the conventional method was used; D,E,F,I, the
alternative method was used to measure the depth of invasion. J,
Both the conventional and alternative method are displayed.
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easier for the pathologist to perform the measure-
ments. Secondly, digital pathology makes it easy to
share pictures of the slides between different patholo-
gists for revision and, more importantly, the point of
deepest invasion and the measurement made by the
pathologist are visible for other consulted pathologists
in case of doubt. Thirdly, digital images enabled the
researchers to perform in-depth analyses of the mea-
surements made and allowed analyses of discrepant
slides and identification of pitfalls.
A possible limitation of our study is the statistical
method used. We dichotomised the measurement of
the individual pathologists into ≤1 and >1 mm, as
these outcomes are clinically relevant. This may have
introduced imprecision, as in some slides the DOI was
very close to 1 mm. We were not able to compare
the kappa for both methods, because the kappa is
dependent on the distribution of the micro- and
macroinvasive slides between the groups (DOI ≤1 and
>1 mm, FIGO stages IA and ≥IB). This distribution
was different for both methods, as the alternative
method is more likely to result in more carcinomas
being classified as microinvasive (DOI ≤1 mm, FIGO
stage IA) compared to the conventional method.
Another limitation is the selection of slides with a
DOI of approximately 1 mm instead of consecutive
series. This might have resulted in an underestima-
tion of the interobserver agreement, and an overesti-
mation of the percentage of slides downgraded from
stage ≥IB, measured by the conservative method to
FIGO stage IA measured by the alternative method.
In conclusion, this study showed only moderate
agreement between pathologists classifying the DOI
into micro- and macroinvasive vulvar SCC (FIGO
stages IA and ≥IB) using the conventional measure-
ment method recommended by the FIGO, and similar
agreement using the alternative method. This study
showed that the alternative method is suitable for
pathologists to measure and classify the DOI in vul-
var SCC. However, before implementing this method
in daily clinical practice, future research should be
performed to determine if the alternative method
leads to a better reflection of the prognosis and of
whether a new threshold needs to be defined to
reflect biological tumour behaviour.
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